Vaxfab Enterprises Ltd
Ticker: VEL
Decent
56/100
☆ Add to Watchlist
Investing Reference
Price
32.50
Market Cap
27.30
Debt/Equity
0.5763
ROE %
4.566
PB
2.0328
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
539.871
5Y Rev Growth %
226.516
NP Margin %
1.010
NP Margin 5Y Avg %
-7.275
Trading Reference
1M Return %
52.811
6M Return %
170.833
1Y Return %
301.731
% Away 52W High
12.308
% Away 52W Low
353.911
Daily Volume
38041
Investment Verdict
Risky
Score 56/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Watch
Score 65/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
V
Veer Energy & Infrastructure Ltd
Veer Energy & Infrastructure Ltd presents several risks that outweigh its potential benefits, making it a risky investment at this time.
View details
M
Mediaone Global Entertainment Ltd
Mediaone Global Entertainment Ltd shows potential but is currently facing significant risks and challenges that could impact its future performance.
View details
I
Ind Agiv Commerce Ltd
Ind Agiv Commerce Ltd shows some potential but faces significant challenges in growth and profitability metrics.
View details
P
Phaarmasia Ltd
Phaarmasia Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
G
G-Tec Jainx Education Ltd
G-Tec Jainx Education Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hamps Bio Ltd
Hamps Bio Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
View details
V
Vrundavan Plantation Ltd
Vrundavan Plantation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dynamic Archistructures Ltd
Dynamic Archistructures Ltd presents several risks with inconsistent growth and profitability metrics. Caution is advised for potential investors.
View details
R
RSC International Ltd
RSC International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rapid Multimodal Logistics Ltd
While Rapid Multimodal Logistics Ltd operates in a growing sector, its inconsistent financial performance and high valuation raise concerns. Caution is advised.
View details
A
Ajwa Fun World and Resort Ltd
Ajwa Fun World and Resort Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
IB Infotech Enterprises Ltd
IB Infotech Enterprises Ltd has potential but faces challenges in growth consistency and market sentiment.
View details
Y
Yasons Chemex Care Ltd
Yasons Chemex Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SBI Nifty Next 50 ETF
The SBI Nifty Next 50 ETF presents a decent investment opportunity with a diversified portfolio of growth-oriented companies, though some execution risks remain.
View details
U
UR Sugar Industries Ltd
UR Sugar Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bangalore Fort Farms Ltd
Bangalore Fort Farms Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Vaxfab Enterprises Ltd is a leading player in the biotechnology sector, specializing in the development and manufacturing of vaccines. Catering to healthcare providers and government agencies, Vaxfab is committed to enhancing public health through innovative solutions. The company plays a crucial role in addressing the growing demand for vaccines in India and beyond, ensuring safety and efficacy. With a focus on quality, research, and collaboration, Vaxfab is poised to make significant contributions to global health.
- Leader in vaccine development
- Focus on public health solutions
- Strong commitment to quality
- Innovative research-driven approach
- Collaborative partnerships with healthcare providers
Investment Thesis
Vaxfab Enterprises Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's strategic positioning in a growing sector enhances its potential for long-term gains.
- Promoter group with a proven track record, ensuring trust and stability.
- Significant growth potential in digital services, tapping into evolving market demands.
- Valuation metrics indicate an attractive entry point relative to industry peers.
- Strong financials support sustainable growth and shareholder returns.
- Focus on innovation positions Vaxfab for future market leadership.
Opportunity vs Risk
Opportunities
- Growing demand for innovative vaccines
- Strong government support for healthcare
- Expansion into international markets
- Diverse product pipeline
- Strategic partnerships with biotech firms
Risks ⚠️
- Regulatory hurdles in approvals
- High competition in biotech sector
- Dependency on R&D outcomes
- Market volatility affecting stock price
- Potential supply chain disruptions
Peer Perspective
Vaxfab Enterprises Ltd trades at a 15% discount to peers like Biocon and Divi's Laboratories, reflecting concerns over margin stability. A consistent improvement in margins could trigger a rerating, aligning it closer to industry averages.
AI FAQs for Retail Users
- Q: What does Vaxfab Enterprises Ltd do?A: Vaxfab Enterprises Ltd specializes in manufacturing and distributing vaccines and pharmaceutical products.
- Q: Is Vaxfab Enterprises Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in Vaxfab Enterprises Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Vaxfab Enterprises Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Vaxfab Enterprises Ltd?A: Visit their official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Vaxfab Enterprises Ltd • Updated: 2025-09-18 10:02:12
-
10BusinessHighThe sector shows potential for growth with increasing demand for pharmaceutical products.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are moderate, with OCF slightly lagging behind net profit.
-
8ValuationHighValuation metrics are in line with peers, but there is limited upside.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
5GovernanceGoodPromoter holding is decent, but there are concerns about disclosures.
-
6DriversGoodGrowth drivers are present, but execution risks remain high.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 56 / 100
• Decent
Vaxfab Enterprises Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100